Previously, Highmark planned to restrict payment for propofol administration during colorectal cancer screening to high-risk patients. Industry organizations, such as the Pennsylvania Society of Gastroenterology and Pennsylvania Society of Anesthesiologists, banded together to fight the restriction. Highmark backed down.
Now, as Medicare waives deductibles and co-insurance for anesthesia during colorectal cancer screening with the beginning of the New Year, Highmark will follow suit, according to the report.
More articles on gastroenterology:
FDA approves new hepatitis C treatment drug
The biggest stories in GI: 4 gastroenterologists look back at 2014
Is there a new colon cancer marker?
